Neoplasia/BPH

	Clinicopathological characteristics and prognostic outcomes of bladder urothelial neoplasms in patients under 40 years of age: a multicenter retrospective study. Virchows Arch Baycelebi D, Icoz AT, Yildirim NA, Okur SN, Kabul S, Simsek GG, Seday SZ, Gunes B, Tasligedik A, Melemezoglu D, Koc Sahin S, Aksoy Khurami F, Cevik Kaya F, Coban G, Ordu M, Y, Sener E, Bolova Bicak T, Kiran MM, Sungu N, Tok B, Kokenek Unal TD, Colak A, Hakkoymaz ZR, Yazgan A, Altindag SD, Bahc, Gokalp Satici FE, Gumuskaya B, Arslan G, Yuyucu Karabulut Y, Kosemehmetoglu K, Yaprak Bayrak B, Akgul M. PMID: 42118290 [PubMed - as supplied by publisher]
	Secondary leukaemia after testicular germ cell tumour treatment: a systematic review and meta-analysis. BJU Int Mousa A, Amiri A, Kaushal S, Wilson E, Tan I, Hamilton RJ. PMID: 42117759 [PubMed - as supplied by publisher]
	Prevalence of erectile dysfunction in men with lower urinary tract symptoms/benign prostatic hyperplasia: a systematic review and meta-analysis. Sex Med Rev Bukyana S, Fillie PC, Kakooza J, Lewis CR, Mukiibi E, Akankwasa P, Bienfait MV, Turyagumanawe J, Inomu E, Kazigo AK, Eltahir EA, Guweddeko IK, Hakizimana T, Demoz A, Anyanwu EG, Muhumuza J, Mugenyi M. PMID: 42117744 [PubMed - indexed for MEDLINE]
	Sexual function outcomes of the 5-year treatment with Rezum compared to doxazosin, finasteride, and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of Prostatic Symptoms Trial. J Sex Med Han TM, Helon J, Long B, Cheema A, Gonzalez N, Joyce C, Feffer M, McVary KT. PMID: 42117741 [PubMed - indexed for MEDLINE]
	Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trial. BJU Int Wei N, Phillips RM, Kwon E, Stish BJ, Ehman EC, Lucien F, O'Byrne J, Bobek O, Shi Q, Andrews JR, Boorjian SA, Park SS, Orme JJ, Sharma V. PMID: 42117295 [PubMed - as supplied by publisher]
	Integrative genomic and functional characterization of FAM3 family genes reveals their diagnostic and prognostic roles in kidney renal clear cell carcinoma. Cytotechnology Zhe W, Abbas M, Abdel-Maksoud MA, Almanaa TN, Almutair S, Alamri A, Aufy M, Al-Qahtani WH, Hameed Y. PMID: 42117032 [PubMed]
	Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study. Int J Urol Shimoda H, Nakamura Y, Inoue M, Yoshinaga A, Kawamura N, Yonese I, Izumi K, Yamamoto T, Uehara S, Suzuki K, Toide M, Takazawa R, Araki S, Fukushima H, Fukuda S, Yuma W, Tanaka H, Yoshida S, Fujii Y. PMID: 42116671 [PubMed - indexed for MEDLINE]
	Efficacy and safety of modified transurethral thulium laser enucleation-resection with apical vaporization cutting versus anatomic thulium laser enucleation for large-volume (> 80â€‰ml) benign prostatic hyperplasia: A retrospective comparative study. Medicine (Baltimore) Li W, Zhang J, Guo J, Wang L, Ma Y, Hou J, Li S. PMID: 42116410 [PubMed - indexed for MEDLINE]
	A Systematic Review on the Impact of Stigma, Anxiety, Depression on Quality of Life Among Prostate Cancer Patients. Psychooncology Rahim MABA, Ismail MB, Noor ABYA. PMID: 42115779 [PubMed - indexed for MEDLINE]
	Deep learning-based automatic field of view planning for prostate MRI in oblique coronal and oblique axial planes. Sci Rep Quinsten AS, Wetter A, Raczkowski M, Trembecki , Guz T, Oliveira S, Buchkremer R, Matusiewicz D, Nassenstein K, Forsting M, Demircio. PMID: 42115680 [PubMed - indexed for MEDLINE]
	Dissecting self-supervised learning strategies for transfer learning in MRI prostate cancer diagnosis. Sci Rep Facuse J, Campanini D, Parra D, Besa C, Salas R, Estévez PA, Mery D. PMID: 42115652 [PubMed - as supplied by publisher]
	Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial. World J Urol Zhang X, Wu Z, Hao L, Qiu X, Xu L, Zhang S, Guo H, Zhuang J. PMID: 42115448 [PubMed - indexed for MEDLINE]
	The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer. Oncogene Cheng B, Gong L, Xu H, Wang Z, Huang H, Guan X, Wu P. PMID: 42115408 [PubMed - as supplied by publisher]
	The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution. Virchows Arch Munari E, Antonini P, Cima L, Polati R, Caliò A, Gobbo STM, Colecchia M, Netto GJ, Antonelli A, Bertolo RG, Grisi C, Litjens G, Brunelli M. PMID: 42115324 [PubMed - as supplied by publisher]
	Androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer: Molecular mechanisms and therapeutic strategies. Urol Oncol Li J, Wang X, Tang X. PMID: 42115122 [PubMed - as supplied by publisher]
	Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Focus De Laere B, Crippa A, Discacciati A, Mortezavi A, Müller C, Røder A, Rannikko A, Ost P, Eklund M, Lindberg J, Grönberg H, ProBio Investigators. PMID: 42115047 [PubMed - as supplied by publisher]
	Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer. J Immunother Cancer Aggarwal R, Zhang J, Monk P, Zhu X, Jones R, Linch M, Costin D, de Bono J, Karsh LI, Petrylak DP, Zhang L, Deshpande R, Borderies P, Huang J, O'Neill V, Donkor M, Tagawa S. PMID: 42114950 [PubMed - indexed for MEDLINE]
	Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort. Radiother Oncol Guricová KM, van Houdt PJ, Salamanca MF, Schoots IG, Agrotis G, Draulans C, Haustermans K, Smeenk RJ, Kunze-Busch M, de Boer HCJ, van der Voort van Zyp JRN, Pos FJ, van der Heide UA. PMID: 42114601 [PubMed - as supplied by publisher]
	Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial. JCO Precis Oncol Armstrong AJ, Saad F, Oya M, Shore N, Procopio G, Arslan C, Mehra N, Brown E, Joung JY, Sugimoto M, Özgüro, Gedye C, Sartor O, Poehlein C, Qiu P, Liu YZ, Li X, Harrington EA, McGuinness D, Kang J, Barnicle A, Clarke N. PMID: 42114035 [PubMed - indexed for MEDLINE]
	Fundamentals of bladder cancer nursing: from diagnosis pathways to holistic care. Br J Nurs Chatterton K. PMID: 42113730 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 187751

Page 1 of 9388



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy